Jaguar Health (JAGX) Accounts Payables (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Accounts Payables data on file, last reported at $5.0 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $5.0 million, down 29.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (down 29.47% YoY), and the FY2025 annual result was $8.7 million, up 64.32% from the prior year.
• Accounts Payables retreated to $5.0 million in Q1 2026 per JAGX's latest filing, from $8.7 million in the prior quarter.
• Over five years, Accounts Payables peaked at $8.7 million in Q4 2025 and troughed at $3.3 million in Q1 2024.
• A 5-year average of $5.6 million and a median of $5.3 million in 2024 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables slumped 41.67% in 2024, then soared 111.69% in 2025.
• A 5-year view of Accounts Payables shows it stood at $5.8 million in 2022, then dropped by 14.36% to $5.0 million in 2023, then gained by 6.27% to $5.3 million in 2024, then jumped by 64.32% to $8.7 million in 2025, then plunged by 42.93% to $5.0 million in 2026.
• Business Quant data shows JAGX's Accounts Payables at $5.0 million in Q1 2026, $8.7 million in Q4 2025, and $8.4 million in Q3 2025.